본문 바로가기
HOME> 논문 > 논문 검색상세

논문 상세정보

Allergy, asthma & immunology research v.2 no.3, 2010년, pp.199 - 205  

The Effects of Lactobacillus rhamnosus on the Prevention of Asthma in a Murine Model

Yu, Jinho    (Department of Pediatrics, Childhood Asthma Atopy Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.   ); Jang, Seong-Ok    (Asan Institute for Life Sciences, University of Ulsan College of Medicine, Seoul, Korea.   ); Kim, Byoung-Ju    (Department of Pediatrics, Childhood Asthma Atopy Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.   ); Song, Young-Hwa    (Department of Pediatrics, Childhood Asthma Atopy Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.   ); Kwon, Ji-Won    (Department of Pediatrics, Childhood Asthma Atopy Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.   ); Kang, Mi-Jin    (Asan Institute for Life Sciences, University of Ulsan College of Medicine, Seoul, Korea.   ); Choi, Won-Ah    (Asan Institute for Life Sciences, University of Ulsan College of Medicine, Seoul, Korea.   ); Jung, Hyun-Don    (Asan Institute for Life Sciences, University of Ulsan College of Medicine, Seoul, Korea.   ); Hong, Soo-Jong    (Department of Pediatrics, Childhood Asthma Atopy Center, Asan Medical Center, University of Ulsa  );
  • 초록

    Purpose Lactobacilli are probiotic bacteria that are effective in the management of allergic diseases or gastroenteritis. It is hypothesized that such probiotics have immunoregulatory properties and promote mucosal tolerance. Our goal was to investigate whether Lactobacillus casei rhamnosus Lcr35 could inhibit airway inflammation in an ovalbumin (OVA)-induced murine model of asthma. Methods BALB/c mice aged 6 weeks were used in the present study. Lactobacillus casei rhamnosus Lcr35 was administered daily, starting 1 week prior to the first OVA sensitization (group 1) and 2 days before the first 1% OVA airway challenge (group 2). Mice that received only saline at both sensitization and airway challenge time points were used as negative controls (group 3), and those that had OVA-induced asthma were used as positive controls (group 4). Airway responsiveness to methacholine was assessed, and bronchoalveolar lavage (BAL) was performed. At the endpoint of the study, total IgE as well as OVA-specific IgE, IgG 1 and IgG 2a in serum was measured by enzyme-linked immunosorbent assay. Lung pathology was also evaluated. Results Airway hyperresponsiveness, total cell counts and the proportion of eosinophils in BAL fluid were significantly decreased in group 1 compared with group 4 ( P 1 and IgG 2a were not significantly influenced by treatment with Lcr35. There was significantly less peribronchial and perivascular infiltration of inflammatory cells in group 1 compared with group 4; however, there were no significant differences in methacholine challenge, BAL, serology or histology between groups 2 and 4. Conclusions Oral treatment with Lcr35 prior to sensitization can attenuate airway inflammation and hyperreactivity in a mouse model of allergic airway inflammation. These results suggest that Lcr35 may have potential for preventing asthma.


  • 주제어

    Asthma .   Lactobacillus rhamnosus .   probiotics .   primary prevention .   animal disease model.  

 활용도 분석

  • 상세보기

    amChart 영역
  • 원문보기

    amChart 영역

원문보기

무료다운로드
유료다운로드
  • 원문이 없습니다.

유료 다운로드의 경우 해당 사이트의 정책에 따라 신규 회원가입, 로그인, 유료 구매 등이 필요할 수 있습니다. 해당 사이트에서 발생하는 귀하의 모든 정보활동은 NDSL의 서비스 정책과 무관합니다.

원문복사신청을 하시면, 일부 해외 인쇄학술지의 경우 외국학술지지원센터(FRIC)에서
무료 원문복사 서비스를 제공합니다.

NDSL에서는 해당 원문을 복사서비스하고 있습니다. 위의 원문복사신청 또는 장바구니 담기를 통하여 원문복사서비스 이용이 가능합니다.

이 논문과 함께 이용한 콘텐츠
이 논문과 함께 출판된 논문 + 더보기